SI1654284T1 - Postopek za pripravo alfa-1-antitripsinske raztopine - Google Patents

Postopek za pripravo alfa-1-antitripsinske raztopine

Info

Publication number
SI1654284T1
SI1654284T1 SI200431155T SI200431155T SI1654284T1 SI 1654284 T1 SI1654284 T1 SI 1654284T1 SI 200431155 T SI200431155 T SI 200431155T SI 200431155 T SI200431155 T SI 200431155T SI 1654284 T1 SI1654284 T1 SI 1654284T1
Authority
SI
Slovenia
Prior art keywords
a1at
preparing
alpha
detergents
antitrypsin solution
Prior art date
Application number
SI200431155T
Other languages
English (en)
Slovenian (sl)
Inventor
Petra Schulz
Jurgen Romisch
Original Assignee
Octapharma Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Octapharma Ag filed Critical Octapharma Ag
Publication of SI1654284T1 publication Critical patent/SI1654284T1/sl

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
    • A61L2/0005Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts
    • A61L2/0082Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts using chemical substances
    • A61L2/0088Liquid substances
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
    • A61L2/0005Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts
    • A61L2/0011Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts using physical methods
    • A61L2/0017Filtration
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
    • A61L2/0005Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts
    • A61L2/0011Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts using physical methods
    • A61L2/0023Heat
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/81Protease inhibitors
    • C07K14/8107Endopeptidase (E.C. 3.4.21-99) inhibitors
    • C07K14/811Serine protease (E.C. 3.4.21) inhibitors
    • C07K14/8121Serpins
    • C07K14/8125Alpha-1-antitrypsin

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Veterinary Medicine (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Pulmonology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicinal Preparation (AREA)
SI200431155T 2003-08-12 2004-08-12 Postopek za pripravo alfa-1-antitripsinske raztopine SI1654284T1 (sl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US49409703P 2003-08-12 2003-08-12
EP04764046A EP1654284B1 (en) 2003-08-12 2004-08-12 Process for preparing an alpha-1-antitrypsin solution
PCT/EP2004/009043 WO2005014648A1 (en) 2003-08-12 2004-08-12 Process for preparing an alpha-1-antitrypsin solution

Publications (1)

Publication Number Publication Date
SI1654284T1 true SI1654284T1 (sl) 2009-10-31

Family

ID=34135316

Family Applications (1)

Application Number Title Priority Date Filing Date
SI200431155T SI1654284T1 (sl) 2003-08-12 2004-08-12 Postopek za pripravo alfa-1-antitripsinske raztopine

Country Status (22)

Country Link
US (1) US20060194300A1 (enExample)
EP (1) EP1654284B1 (enExample)
JP (1) JP4668904B2 (enExample)
KR (1) KR20060070543A (enExample)
CN (1) CN1867582B (enExample)
AT (1) ATE428730T1 (enExample)
AU (1) AU2004262578B2 (enExample)
BR (1) BRPI0412835A (enExample)
CA (1) CA2534900A1 (enExample)
DE (1) DE602004020632D1 (enExample)
DK (1) DK1654284T3 (enExample)
ES (1) ES2324168T3 (enExample)
IL (1) IL172868A0 (enExample)
NO (1) NO20060109L (enExample)
PL (1) PL1654284T3 (enExample)
PT (1) PT1654284E (enExample)
RS (1) RS20060077A (enExample)
RU (1) RU2370500C2 (enExample)
SI (1) SI1654284T1 (enExample)
UA (1) UA86775C2 (enExample)
WO (1) WO2005014648A1 (enExample)
ZA (1) ZA200601206B (enExample)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE602004013021T3 (de) * 2003-09-22 2012-04-05 Kamada Ltd. Herstellung eines alpha-1-proteinaseinhibitors im grossmassstab und dessen verwendung
ES2246695B1 (es) 2004-04-29 2007-05-01 Instituto Cientifico Y Tecnologico De Navarra, S.A. Composicion estimuladora de la respuesta inmunitaria que comprende nanoparticulas a base de un copolimero de metil vinil eter y anhidrido maleico.
ES2246694B1 (es) 2004-04-29 2007-05-01 Instituto Cientifico Y Tecnologico De Navarra, S.A. Nanoparticulas pegiladas.
CN100354301C (zh) * 2005-10-13 2007-12-12 南京工业大学 化学合成多肽的新型大规模分离制备技术
CA2703393C (en) 2007-11-02 2018-07-24 Talecris Biotherapeutics, Inc. Method, composition, and article of manufacture for providing alpha-1 antitrypsin
CN102127165B (zh) * 2010-01-15 2013-09-04 上海莱士血液制品股份有限公司 一种从血浆组分四沉淀中制备高纯ApoA-I的生产工艺
CN102731642B (zh) * 2011-04-14 2014-01-29 上海莱士血液制品股份有限公司 从人血浆组分四沉淀制备高纯Apoa-I的生产工艺
US9353165B2 (en) * 2012-07-25 2016-05-31 Grifols, S.A. Purification of cell culture derived alpha1 protease inhibitor
AU2013205138B2 (en) * 2012-08-09 2015-06-25 Grifols, S.A. Caprylate Viral Deactivation
JP6845813B2 (ja) 2015-06-26 2021-03-24 フェリング ベスローテン フェンノートシャップ 精製および/またはウイルス不活性化の方法
AU2017214678B2 (en) * 2016-02-03 2024-02-01 Plasma Technologies, Llc Methods for extracting proteins from a blood-based material
CN111511800B (zh) 2017-10-30 2023-11-28 武田药品工业株式会社 灭活脂包膜病毒的环境相容性去污剂
CN111991571B (zh) * 2020-08-12 2022-04-05 湖州师范学院 一种柱上低pH病毒灭活的方法

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS584728A (ja) * 1981-05-01 1983-01-11 メデイカル・リサ−チ・インステイチユ−ト・オブ・サンフランシスコ・コ−ポレ−シヨン α−1−抗トリプシンの精製
US4379087A (en) * 1982-06-17 1983-04-05 Cutter Laboratories, Inc. Method of preparing alpha-1-proteinase inhibitor
US4684723A (en) * 1985-09-11 1987-08-04 Miles Laboratories, Inc. Method of separating proteins from aqueous solutions
US4629567A (en) * 1986-03-07 1986-12-16 Smithkline-Rit Alpha-1-antiprotease purification
EP0288841B1 (en) * 1987-04-27 1992-12-30 Miles Inc. Method of preparing highly purified alpha-1-proteinase inhibitor
KR920005689B1 (ko) * 1989-12-21 1992-07-13 국제약품공업주식회사 혈청으로부터 알파-1-안티트립신의 분리 정제 및 혈중 알파-1-안티트립신 양의 검정키트
DE4125625C2 (de) * 1991-08-02 1999-12-02 Octapharma Ag Glarus Verfahren zur Herstellung von virusinaktivierten Immunglobulinlösungen
SE9301582D0 (sv) * 1993-05-07 1993-05-07 Kabi Pharmacia Ab Purification of plasma proteins
DE4407837C1 (de) * 1994-03-09 1995-08-17 Octapharma Ag Verfahren zur Gewinnung von hochreinem, virusinaktiviertem alpha¶1¶-Antitrypsin mittels Anionenaustauscher-Chromatographie
US6284874B1 (en) * 1994-06-17 2001-09-04 Alpha Therapeutic Corporation Process for separating α1-proteinase inhibitor from cohn fraction IV1 and IV4 paste
EP1736483A3 (en) * 1995-09-07 2008-07-30 Pharming Intellectual Property BV Purification of alpha-1 proteinase inhibitor
JP4105249B2 (ja) * 1996-08-09 2008-06-25 財団法人化学及血清療法研究所 α2プラスミンインヒビターの製造方法
AT407114B (de) * 1997-06-10 2000-12-27 Immuno Ag Alpha 1-antitrypsin-präparation sowie verfahren zu deren herstellung

Also Published As

Publication number Publication date
AU2004262578A1 (en) 2005-02-17
AU2004262578B2 (en) 2010-05-06
DE602004020632D1 (de) 2009-05-28
DK1654284T3 (da) 2009-07-20
CN1867582B (zh) 2010-06-16
CA2534900A1 (en) 2005-02-17
CN1867582A (zh) 2006-11-22
PL1654284T3 (pl) 2009-09-30
BRPI0412835A (pt) 2006-09-26
US20060194300A1 (en) 2006-08-31
ATE428730T1 (de) 2009-05-15
ZA200601206B (en) 2007-05-30
NO20060109L (no) 2006-02-15
EP1654284B1 (en) 2009-04-15
RU2370500C2 (ru) 2009-10-20
JP4668904B2 (ja) 2011-04-13
UA86775C2 (ru) 2009-05-25
RU2006107533A (ru) 2006-07-27
EP1654284A1 (en) 2006-05-10
RS20060077A (sr) 2008-08-07
WO2005014648A1 (en) 2005-02-17
KR20060070543A (ko) 2006-06-23
ES2324168T3 (es) 2009-07-31
IL172868A0 (en) 2006-06-11
JP2007523883A (ja) 2007-08-23
PT1654284E (pt) 2009-07-06

Similar Documents

Publication Publication Date Title
IL172868A0 (en) Process for preparing an alpha-1-antitrypsin solution
RU95108231A (ru) Glp-1-молекулярный комплекс, фармацевтическая композиция и способ получения комплекса
TW200505480A (en) High concentration antibody and protein formulations
YU23599A (sh) Stabilizovani antihistaminski sirup
EP2767291A3 (en) Treatment of glycogen storage disease type II
NZ527123A (en) Oxazolyl-pyrazole derivatives as kinase inhibitors
ES8702793A1 (es) Un procedimiento para desinfectar un substrato
ATE398128T1 (de) Neue purinderivate, deren herstelllung und deren verwendung als arzneimittel
GB0406281D0 (en) A system for extracting tetrodotoxin
WO2004037784A3 (en) Pyrrolidones with anti-hiv activity
NO20006606D0 (no) Fremgangsmåte for fremstilling av en vandig monoester peroksykarboksylsyreopplösning, opplösningen som kan oppnås ved denne fremgangsmåten og dens anvendelse som desinfeksjonsmiddel
BR0307236A (pt) Processo para fabricação de compostos orgânicos
WO2003030886A3 (en) Allylamides useful in the treatment of alzheimer's disease
GB2383041A (en) Process for the preparation of gabapentin
MX2009004690A (es) Sistema y proceso para producir una solucion de solidos poco suspendidos y usos de la misma.
ATE272436T1 (de) Mikrofiltration unter verwendung von aktivkohle
SE0200843D0 (sv) Chemical compounds
GB2411401A (en) Process for production of alkanesulfonic acid
PL1718673T3 (pl) Sposób oczyszczania albuminy obejmujący etap nanofiltracji, roztwór, i zawierająca go kompozycja do terapeutycznego zastosowania
WO2004037853A3 (en) Quinolones with anti-hiv activity
MY118316A (en) Synthesis of heteropolyacids
IT1265964B1 (it) Micro-granuli ottenuti tramite estrusione-sferonizzazione contenenti una ciclodestrina.
SE9904289D0 (sv) Method and camposition for the treatment of adenovairal ocular infections
EA199900892A1 (ru) Способ удаления тяжелых металлов
DE60325731D1 (en) Monopropylenglykol als fermentationszusatz